GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Perpetua Medical AB (publ) PERP B.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

1.74

+5.45%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Perpetua Medical AB (publ)

Its shares trade on Nasdaq Stockholm under the ticker PERP B.ST. It has been listed since 6 August 2015. In the fiscal year to 31 December 2025, it reported revenue of SEK 14.6m and net income of SEK 2.5m. At that date it held total assets of SEK 62.2m and shareholders' equity of SEK 19.8m.

Pharmacolog i Uppsala AB engages in the provision of quality assurance solutions for safe administration of drugs. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2015-08-06. The company’s main product, DrugLog, focuses on quality assurance in drug administration in the hospital pharmacy and the clinical ward.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
6 Aug 2015

Leadership

Pay as last reported

  • Mr. Erik HedlundIndependent Chairman of the Board, since 2017
  • Mr. Lars GuschChief Executive Officer
  • Ms. LiseLotte SoderChief Financial Officer
  • Mr. Kent ObrinkSales & Marketing Manager
  • Ms. Susanne GrimsbyManager QA-RA
  • Mr. Torbjorn NorbergProduct Manager
  • Ms. Asa StroofeMarketing Manager
  • Mr. Kiarash FarrIndependent Director
  • Mr. Henrik Magnusson HjorthIndependent Director
  • Dr. Ragnar LinderIndependent Director
  • Mr. Wilhelm RisbergIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Pharmacolog provides quality assurance solutions for safe drug administration.
  • The main product DrugLog focuses on hospital pharmacy and clinical ward quality.
  • The company is headquartered in Uppsala, Sweden.

Weaknesses

  • The source description is explicitly treated as untrusted facts.
  • Specific financial data or market share figures are not provided.
  • No information on profitability or revenue streams is available.

Opportunities

  • Expanding DrugLog to other healthcare facilities beyond hospitals.
  • Integrating with new electronic health record systems.
  • Growing demand for patient safety and medication error prevention.

Threats

  • Competitors may offer similar quality assurance software solutions.
  • Changes in healthcare regulations could impact product requirements.
  • Adoption rates may be slow due to existing legacy systems.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.